Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

February 01, 1998; Volume 26,Issue 2

Accelerated Communication

  • You have access
    Metabolic Screening Using On-Line Ultrafiltration Mass Spectrometry
    Richard B. van Breemen, Dejan Nikolic and Judy L. Bolton
    Drug Metabolism and Disposition February 1998, 26 (2) 85-90;

Articles

  • You have access
    Phase II-Selective Induction of Hepatic Drug-Metabolizing Enzymes by Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione], 1,7-Phenanthroline, and 2,2′-Dipyridyl in Rats Is Not Accompanied by Induction of Intestinal Enzymes
    Maricelly Vargas, John G. Lamb and Michael R. Franklin
    Drug Metabolism and Disposition February 1998, 26 (2) 91-97;
  • You have access
    Disposition and Covalent Binding of Diflunisal and Diflunisal Acyl Glucuronide in the Isolated Perfused Rat Liver
    Min Wang and Ronald G. Dickinson
    Drug Metabolism and Disposition February 1998, 26 (2) 98-104;
  • You have access
    Identification and Characterization of in VitroMetabolites of 2-[2′-(Dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-dione (Azonafide)
    Craig A. Mayr, Salah M. Sami, William A. Remers and Robert T. Dorr
    Drug Metabolism and Disposition February 1998, 26 (2) 105-109;
  • You have access
    Relationship between Hepatic Cytochrome P450 3A Content and Activity and the Disposition of Midazolam Administered Orally
    C. Wandel, R. H. Böcker, H. Böhrer, J. X. deVries, W. Hofmann, K. Walter, B. Kleingeist, S. Neff, R. Ding, I. Walter-Sack and E. Martin
    Drug Metabolism and Disposition February 1998, 26 (2) 110-114;
  • You have access
    Excretion and Metabolism of the Antihypertensive Agent, RWJ-26240 (McN-5691) in Dogs
    W. N. Wu, J. A. Masucci, G. W. Caldwell and J. R. Carson
    Drug Metabolism and Disposition February 1998, 26 (2) 115-125;
  • You have access
    Pharmacokinetics of Erythropoietin in Genetically Anemic Mice
    Motohiro Kato, Kumi Miura, Hiroshi Kamiyama, Akira Okazaki, Kenji Kumaki, Yukio Kato and Yuichi Sugiyama
    Drug Metabolism and Disposition February 1998, 26 (2) 126-131;
  • You have access
    Degradation Products of Beclomethasone Dipropionate in Human Plasma
    Kuncoro Foe, H.T. Andrew Cheung, Bruce N. Tattam, Kenneth F. Brown and J. Paul Seale
    Drug Metabolism and Disposition February 1998, 26 (2) 132-137;
  • You have access
    Stereoselective Uptake of an Organic Anion Across the Renal Basolateral Membrane in Isolated Perfused Rat Kidney
    Kazutaka Higaki, Tadahiko Yukawa, Masaharu Takeuchi, Kenichi Nezasa and Masayuki Nakano
    Drug Metabolism and Disposition February 1998, 26 (2) 138-145;
  • You have access
    Disposition and Metabolism of a Novel Antineoplastic Agent, 4-tert-Butyl-[3-(2-chloroethyl)ureido]benzene, in Mice
    Jean-Claude Maurizis, Maryse Rapp, El Mostafa Azim, René C. Gaudreault, Annie Veyre and Jean-Claude Madelmont
    Drug Metabolism and Disposition February 1998, 26 (2) 146-151;
  • You have access
    Species Differences in Pharmacokinetics of a Hepatoprotective Agent, YH439, and Its Metabolites, M4, M5, and M7, after Intravenous and Oral Administration to Rats, Rabbits, and Dogs
    Woo H. Yoon, Jung K. Yoo, Jong W. Lee, Chang-K. Shim and Myung G. Lee
    Drug Metabolism and Disposition February 1998, 26 (2) 152-163;
  • You have access
    Stereoselective Disposition of Propranolol in Rabbits
    Jean-François Marier, Vincent Pichette and Patrick du Souich
    Drug Metabolism and Disposition February 1998, 26 (2) 164-169;
  • You have access
    Enantioselectivity of the Enterohepatic Recycling of Carprofen in the Dog
    Nathalie Priymenko, Francois Garnier, Jean-P. Ferre, Paul Delatour and Pierre-L. Toutain
    Drug Metabolism and Disposition February 1998, 26 (2) 170-176;

Short Communications

  • You have access
    Evidence for Metabolic Activation of N′-Nitrosonornicotine and N-Nitrosobenzylmethylamine by a Rat Nasal Coumarin Hydroxylase
    Christopher J. Patten, Lisa A. Peterson and Sharon E. Murphy
    Drug Metabolism and Disposition February 1998, 26 (2) 177-180;
  • You have access
    Microsomal Formation of a Pyrrolic Alcohol Glutathione Conjugate of Clivorine
    Ge Lin, Yan-Yan Cui and Edward M. Hawes
    Drug Metabolism and Disposition February 1998, 26 (2) 181-184;
  • You have access
    Sequences of Intestinal and Hepatic Cytochrome P450 3A4 cDNAs are Identical
    Kenneth S. Lown, Mita Ghosh and Paul B. Watkins
    Drug Metabolism and Disposition February 1998, 26 (2) 185-187;
  • You have access
    Mutual Inhibition between Quinine and Etoposide by Human Liver Microsomes
    Xue-Jun Zhao, Takashi Kawashiro and Takashi Ishizaki
    Drug Metabolism and Disposition February 1998, 26 (2) 188-191;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 26, Issue 2
1 Feb 1998
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Short Communications
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Alternative P450 Splicing Redirects Human Drug Metabolism
  • Switch from CAR to PXR in the Presence of EGF
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics